Next Article in Journal
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
Previous Article in Journal
A Tractable and Efficient One-Pot Synthesis of 5'-Azido-5'-deoxyribonucleosides
Article Menu

Export Article

Open AccessArticle
Molecules 2014, 19(2), 2445-2457; doi:10.3390/molecules19022445

Preparation and In Vitro Evaluation of Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carriers

Department of Pharmacy, The First Affiliated Hospital of China Medical University, 155 Nanjing Street, Shenyang 110001, China
Department of The First Clinical Pharmacy, China Medical University, 92 Bei'er Road, Shenyang 110001, China
Department of Pharmacy, Central Hospital Attached to Shenyang Medical College, No. 5 the 7th south-west Road, TieXi district, Shenyang 110024, China
School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Street, Shenyang 110016, China
Author to whom correspondence should be addressed.
Received: 14 November 2013 / Revised: 11 February 2014 / Accepted: 17 February 2014 / Published: 21 February 2014
View Full-Text   |   Download PDF [1134 KB, uploaded 18 June 2014]   |  


Curcumin, a phenolic antioxidant compound derived from the rhizome of the turmeric plant Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion and apoptosis, revealing its anticancer potential. In this study, a Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carrier (Cur-GA-PEG-NLC) was prepared by the film ultrasound method to improve the tumor-targeting ability. The drug content was detected by an UV spectrophotometry method. The encapsulation efficiency of curcumin in the nanostructured lipid carriers (NLCs) was determined using a mini-column centrifugation method. The encapsulation efficiency for various Cur-GA-PEG-NLC was within the range of 90.06%–95.31% and particle size was between 123.1 nm and 132.7 nm. An in vitro MTT assay showed that Cur-GA10%-PEG-NLC had significantly high cellular uptake and cytotoxicity against HepG2 cells compared with other groups. View Full-Text
Keywords: curcumin; glycyrrhetinic acid; nanostructured lipid carriers; anti-HepG2 curcumin; glycyrrhetinic acid; nanostructured lipid carriers; anti-HepG2

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Chu, Y.; Li, D.; Luo, Y.-F.; He, X.-J.; Jiang, M.-Y. Preparation and In Vitro Evaluation of Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carriers. Molecules 2014, 19, 2445-2457.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top